H.C. Wainwright raised the firm’s price target on Surrozen (SRZN) to $44 from $36 and keeps a Buy rating on the shares. The firm cites Surrozen’s continued platform progress towards an SZN-8141 submission in the second half of 2026 for the target bump.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRZN:
- Surrozen Earns Buy Rating on Advancing Retinal Pipeline, Strong Cash Runway, and Large wAMD/DME Market Opportunity
- Surrozen reports Q1 EPS ($11.65) vs. ($7.43) last year
- Surrozen management to meet with Cantor
- Surrozen: Buy Rating Reiterated as Analyst Highlights Wnt-Targeted Ophthalmology Strategy and Maintains $37 Price Target
- Surrozen initiated with a Buy at TD Cowen